First Quadrant’s Teladoc Health TDOC Stock Holding History

First Quadrant’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,457	Closed	-$242K	–	554
2021 Q2	$242K	Buy	1,457 +54	+4%	+$8.75K	0.03%	323
2021 Q1	$255K	Hold	1,403	–	–	0.03%	341
2020 Q4	$281K	Buy	1,403 +1,293	+1,175%	+$263K	0.03%	322
2020 Q3	$24K	Buy	+110	New	+$23.3K	﹤0.01%	537

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

First Quadrant's TDOC Position: Q3 2021 in Review

First Quadrant sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 1,457 shares — an estimated $242K sold.

First Quadrant first reported a position in TDOC in Q3 2020 and held it in 4 quarters. The position peaked at $281K in Q4 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

First Quadrant reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
First Quadrant sold 1,457 Teladoc Health shares in Q3 2021, an estimated $242K.
First Quadrant first reported a position in Teladoc Health in Q3 2020 and held it in 4 quarters.
First Quadrant's Teladoc Health position peaked at $281K in Q4 2020.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on First Quadrant's 13F filing for Q3 2021, filed 26 Oct 2021.